Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective

about

Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective

Item

http://www.wikidata.org/entity/Q56380502

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2018

@uk

name

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@en

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@nl

type

Item

label

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@en

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@nl

prefLabel

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@en

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@nl

P1476

Timing of Anticoagulation for ...... US Hepatologist's Perspective

@en

P2093

Jessica P E Davis

http://www.w3.org/2001/XMLSchema#string

Patrick G Northup

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.

Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.

Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.

Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

The coagulopathy of chronic liver disease.

Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2478/JTIM-2018-0001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29607296

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

thrombosis

anticoagulation

P932

5874479

http://www.w3.org/2001/XMLSchema#string